ALK-Abelló A/S (OTC:AKBLF – Get Free Report) rose 1.8% during mid-day trading on Tuesday . The company traded as high as $36.10 and last traded at $36.10. Approximately 100 shares traded hands during mid-day trading, a decline of 64% from the average daily volume of 274 shares. The stock had previously closed at $35.45.
ALK-Abelló A/S Trading Up 1.8%
The company’s fifty day moving average is $34.65 and its 200 day moving average is $31.06.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
See Also
- Five stocks we like better than ALK-Abelló A/S
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
